Oprozomib
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Oprozomib, covering 2017-05-02 to 2021-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma [Phase 1]